Please assess the completion status of the following clinical trial:

Trial Title: Oral Azithromycin Versus Doxycycline in Posterior Blepharitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients were diagnosed with posterior blepharitis if they scored at least one in two symptoms (based on a subjective grading scale) and two signs (based on an objective grading scale) of posterior blepharitis according to study criteria~Exclusion Criteria:~Patients were excluded if they had the following criteria: age\< 12 years old,history of previous ocular or lacrimal surgery,previous usage of contact lenses,any history of ocular allergy,history of systemic diseases with ocular involvement (except rosacea), history of usage of topical or systemic antibiotic in the last month, pregnancy or lactating mothers, liver failure and any history of sensitivity to cyclines

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Oral Azithromycin (Type: EXPERIMENTAL): Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.
- Doxycycline (Type: ACTIVE_COMPARATOR): Oral doxycycline 100mg capsule every 12 hours for one month

Based on this trial design, predict the completion outcome and termination type (if applicable).